![glp 1 agonist metformin Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://www.uspharmacist.com/CMSImagesContent/2011/5/USD1101-GLP-F1.gif)
glp 1 agonist metformin Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus glp-1_analogs [TUSOM | Pharmwiki]
Description
[DOI] [Google Scholar] 27.Jia G., Hill M
![glp 1 agonist metformin Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Extending its duration of action has become a key focus in drug development
![glp 1 agonist metformin Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/387719938/figure/fig4/AS:11431281388598887@1745185793531/Diagram-summarizing-how-metformin-gliclazide-GLP-1-receptor-agonists-and-SGLT-2_Q320.jpg)
doi:10.1016/j.expneurol.2013.11.001 182
![glp 1 agonist metformin Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S1056872721001690-gr1.jpg)
Side effects included nausea (16% of patients), diarrhea (2%) and vomiting (2%) [38]
![glp 1 agonist metformin Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus glp-1_analogs [TUSOM | Pharmwiki]](https://www.frontiersin.org/files/Articles/882998/xml-images/fendo-13-882998-g001.webp)
What started as a market barely worth $1 billion in 2020 is now on track to hit a staggering $100 billion by 2030
